Hims & Hers Health Inc (NYSE:HIMS) shares, rose in value, with the stock price up by 0.08% to the previous day’s close as strong demand from buyers drove the stock to $12.34.
Actively observing the price movement in the last trading, the stock closed the session at $12.33. Referring to stock’s 52-week performance, its high was $17.16, and the low was $5.65. On the whole, HIMS has fluctuated by -24.34% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 1.19B, with a low estimate of 268.9M and a high estimate of 271.65M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 270.45M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that HIMS’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of HIMS currently trading nearly -12.39% and -8.50% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 36.46, while the 7-day volatility ratio is showing 4.27% which for the 30-day chart, stands at 5.12%. Furthermore, Hims & Hers Health Inc (HIMS)’s beta value is 0.96, and its average true range (ATR) is 0.72.
A comparison of Hims & Hers Health Inc (HIMS) with its peers suggests the former has fared considerably weaker in the market. HIMS showed an intraday change of 0.08% in last session, and over the past year, it grew by 4.49%%.
Data on historical trading for Hims & Hers Health Inc (NYSE:HIMS) indicates that the trading volumes over the past 3 months, they’ve averaged 5.10 million. According to company’s latest data on outstanding shares, there are 205.10 million shares outstanding.
Nearly 34.85% of Hims & Hers Health Inc’s shares belong to company insiders and institutional investors own 38.77% of the company’s shares. The stock has risen by 38.65% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the HIMS stock heading into the next quarter.
